期刊
SCIENCE
卷 291, 期 5509, 页码 1790-1792出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1058092
关键词
-
资金
- NCI NIH HHS [CA 66736] Funding Source: Medline
- NIGMS NIH HHS [GM 22172] Funding Source: Medline
The macrocyclic core of the antibiotic erythromycin, 6-deoxyerythronolide B (6dEB), is a complex natural product synthesized by the soil bacterium Saccharopolyspora erythraea through the action of a multifunctional polyketide synthase (PKS). The engineering potential of modular PKSs is hampered by the Limited capabilities for molecular biological manipulation of organisms (principally actinomycetes) in which complex polyketides have thus far been produced. To address this problem, a derivative of Escherichia coli has been genetically engineered. The resulting cellular catalyst converts exogenous propionate into 6dEB with a specific productivity that compares well with a high-producing mutant of S. erythraea that has been incrementally enhanced over decades for the industrial production of erythromycin.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据